A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders

ISSN： 1562-2975

Source： World Journal of Biological Psychiatry, Vol.12, Iss.7, 2011-10, pp. : 501-515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differentiating Bipolar Disorders from Major Depressive Disorders: Treatment Implications

By Muzina David Kemp David McIntyre Roger

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 19, Iss. 4, 2007-10 ,pp. : 305-312

Informa Healthcare

Access to resources Recommend Favorite

Repeated suicidal behaviour: Stressful life events and 5-HTTLPR genetic polymorphism

By Schillani Giulia Goljevscek Serena Carlino Davide De Vanna Maurizio Aguglia Eugenio Giraldi Tullio

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 3, 2009-09 ,pp. : 229-232

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The pharmacological treatment of childhood anxiety disorders

By Walkup John T. Labellarte Michael J. Ginsburg Golda S.

International Review of Psychiatry, Vol. 14, Iss. 2, 2002-05 ,pp. : 135-142

Informa Healthcare

Access to resources Recommend Favorite

5‐HTTLPR genotype potentiates the effects of war zone stressors on the emergence of PTSD, depressive and anxiety symptoms in soldiers deployed to iraq

World Psychiatry, Vol. 14, Iss. 2, 2015-06 ,pp. : 198-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

By Vigo Daniel Baldessarini Ross

Harvard Review of Psychiatry, Vol. 17, Iss. 4, 2009-08 ,pp. : 231-241

Ashgate Publishing Ltd

Access to resources Recommend Favorite